PAZOPANIB HYDROCHLORIDE
Clinical safety rating: avoid
Contraindicated (not allowed)
Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.
Tablet 200 mg - Oral
Clinical note
Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause hepatotoxicity and QT prolongation.
Diarrhea
Loading safety data…